EP4178548
LYFJASAMSETNINGAR SEM SAMANSTANDA AF (S)-4-(4-(4-(((2-(2,6-DÍOXÓPÍPERIDÍN-3-ÝL)-1-OXÓÍSÓINDÓLÍN-4- ÝL)OXÝ)M ETÝL)BENSÝL)PÍPERASÍN-1-ÝL)-3-FLÚORÓBENSÓNÍTRÍL OG AÐFERÐIR TIL NOTKUNAR ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.7.2021EP published:
24.7.2024EP application number:
21755119.1
EP translation filed:
29.8.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
5.7.2041Expiry date:
5.7.2026Next due date:
31.7.2026
Title in English:
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)M ETHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAMELanguage of the patent:
English
Timeline
Today
6.7.2021EP application
24.7.2024EP Publication
29.8.2024Translation submitted
15.10.2024Registration published
5.7.2026Expires
Owner
Name:
Celgene CorporationAddress:
Route 206 & Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
AGRAWAL, AnjaliAddress:
Summit, NJ 07901, US
Name:
MITRA, Biplob, K.Address:
Summit, NJ 07901, US
Name:
THOOL, Prajwal, GunwanthAddress:
Summit, NJ 07901, US
Name:
HIGGINS-GRUBER, ShannonAddress:
Summit, NJ 07901, US
Name:
RODRIGUEZ, Jennifer, AlmodovarAddress:
Summit, NJ 07901, US
Name:
LIU, DeminAddress:
Summit, NJ 07901, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202063048998 PDate:
7.7.2020Country:
US
Classification
Categories:
A61K 9/16, A61K 9/48, A61P 35/00, A61P 1/00, A61K 31/496
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 4.7.2025
Expires: 5.7.2026
Payer: Árnason Faktor ehf.